Advances in long-acting injectables, implants, and vaginal rings for contraception and HIV prevention

SA Krovi, LM Johnson, E Luecke, SL Achilles… - Advanced drug delivery …, 2021 - Elsevier
Worldwide, women face compounding reproductive health risks, including human
immunodeficiency virus (HIV), sexually-transmitted infections (STIs), and unintended …

Preferences for pre-exposure prophylaxis for HIV: a systematic review of discrete choice experiments

LPL Wulandari, SY He, CK Fairley, BR Bavinton… - …, 2022 - thelancet.com
Background We aimed to systematically review the health preference literature using
discrete choice experiments (DCEs), an attribute-based stated preference method, to …

Eliciting preferences for HIV prevention technologies: a systematic review

SW Beckham, NL Crossnohere, M Gross… - The Patient-Patient …, 2021 - Springer
Background Many human immunodeficiency virus (HIV) prevention technologies (pre-
exposure prophylaxis, microbicides, vaccines) are available or in development. Preference …

Women want choices: opinions from the share. learn. shape global internet survey about multipurpose prevention technology (MPT) products in development

BA Friedland, M Plagianos, C Savel, V Kallianes… - AIDS and Behavior, 2023 - Springer
Women need multipurpose prevention technologies (MPTs) to simultaneously prevent
sexually transmitted infections (STIs), including HIV, with or without contraception. User …

Health economics research on non-surgical biomedical HIV prevention: identifying gaps and proposing a way forward

S Torres-Rueda, F Terris-Prestholt, M Gafos… - …, 2023 - Springer
Abstract Background and Objective Although HIV prevention science has advanced over the
last four decades, evidence suggests that prevention technologies do not always reach their …

Preferences for HIV preexposure prophylaxis products among black women in the US

WC Irie, SK Calabrese, RR Patel, KH Mayer… - AIDS and Behavior, 2022 - Springer
In a nationwide sample of Black women in the US, we assessed preferences for HIV
preexposure prophylaxis (PrEP) products, including long-acting injectable (LAI) PrEP and …

Controlled delivery via hot-melt extrusion: a focus on non-biodegradable carriers for non-oral applications

I Koutsamanis, E Roblegg, M Spoerk - Journal of Drug Delivery Science …, 2023 - Elsevier
Hot-melt extrusion (HME) has an esteemed place in the pharmaceutical industry with
significant applications and advancements spreading over 30 years of development …

[HTML][HTML] Synthesis of end-user research to inform future multipurpose prevention technologies in sub-Saharan Africa: a scoping review

NL Bhushan, K Ridgeway, EH Luecke… - … in Reproductive Health, 2023 - frontiersin.org
Introduction: Women in sub-Saharan Africa (SSA) experience disproportionately high rates
of HIV infection and unintended pregnancy compared to their age-matched counterparts in …

Pharmacokinetic study of islatravir and etonogestrel implants in macaques

MB Daly, A Wong-Sam, L Li, A Krovi, GJ Gatto… - Pharmaceutics, 2023 - mdpi.com
The prevention of HIV and unintended pregnancies is a public health priority. Multi-purpose
prevention technologies capable of long-acting HIV and pregnancy prevention are desirable …

[HTML][HTML] Optimizing the pipeline of multipurpose prevention technologies: opportunities across women's reproductive lifespans

A Bershteyn, D Resar, HY Kim, I Platais… - … in Reproductive Health, 2023 - frontiersin.org
HIV/AIDS and maternal mortality are the two leading causes of death among women of
reproductive age in sub-Saharan Africa. A growing body of research investigates …